1. Noordenbos W. Pain. Amsterdam: Elsevier, 1959.
2. Gracely RH, Dubner R. Pain assessment in humans—a reply to Hall. Pain 1981; 11(1):109-120.
3. Price Dd et al. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002; 99(1-2):49-59.
4. Myles PS et al. The pain visual analog scale: is it linear or nonlinear? Anesth Analg 1999; 89(6): 1517-1520.
5. Price DD et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17(1):45-56.
6. Price DD et al. The N-methyl-d-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59(2):165-174.
7. Price DD, Riley JL, Wade JB. Psychophysical approaches to the measurement of the dimensions and stages of pain. In: Turk DC, Melzack R, eds. Handbook of Pain Measurement. New York: The Guilford Press, 2001:115-134.
8. Rosier EM, Iadarola MJ, Coghill RC. Reproducibility of pain measurement and pain perception. Pain 2002; 98(1-2):205-216.
9. Price DD, Harkins SW. The combined use of visual analogue scales and experimental pain in providing standardized measurement of clinical pain. Clin J Pain 1987; 3:1-8.
10. Price DD et al. A simultaneous comparison of fentanyl's analgesic effects on experimental and clinical pain. Pain 1986; 24(2):197-203.
11. Price DD. Psychological Mechanisms of Pain and Analgesia. Seattle: IASP Press, 1999.
12. Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the subjective experience of pain. Proc Natl Acad Sci USA 2003; 100(14):8538-8542.
13. Price DD et al. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994; 56(2):217-226.
14. Dworkin RH et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005; 113(1-2):9-19.
15. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York: The Guilford Press, 2001:135-151.
16. Yeomans DC, Proudfit HK. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: electrophysiological evidence. Pain 1996; 68(1):141-150.
17. Price DD, Long S, Huitt C. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 1992; 49(2):163-173.
18. Janig W, Stanton-Hicks M. Reflex sympathetic dystrophy: a reappraisal. Seattle: IASP Press, 1996.
19. Campbell JN, Raja SN, Meyer RA. Painful sequelae of nerve injury. In: Dubner R, Gebhart GF, Bond MR, eds. Pain Research and Clinical Management. New York: Elsevier, 1988:135-143.
20. Meyer RA, Campbell JN. Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand. Science 1981; 213(4515):1527-1529.
21. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992; 51(2):175-194.
22. Staud R et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91(1-2):165-175.
23. Staud R et al. Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 2003; 105(1-2):215-222.
24. Staud R et al. Maintenance of windup of second pain requires less frequent stimulation in fibromyal-gia patients compared to normal controls. Pain 2004; 110(3):689-696.
25. Vierck CJ Jr et al. The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J Pain 2001; 2(6):334-344.
26. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1983; 10(6): 965-968.
27. Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20(3):469-474.
28. Russell IJ et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37(11):1593-1601.
29. Price DD. Characteristics of second pain and flexion reflexes indicative of prolonged central summation. Exp Neurol 1972; 37(2):371-387.
30. Price DD et al. Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 1977; 3(1):57-68.
31. Vierck CJ Jr et al. Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J Neurophysiol 1997; 78(2):992-1002.
32. Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitization. Pain 1999; 79(1):75-82.
33. Mendell LM, Wall PD. Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 1965; 206:97-99.
34. Staud R et al. Effects of the NMDA receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal controls. J Pain 2005; 6(5):323-332.
35. Merritt AM et al. Evaluation of method to experimentally induce colic in horses and the effects of acupuncture applied at the Guan-yuan-shu (similar to BL-21) acupoint. Am J Vet Res 2002; 66(5): 897-906.
36. Maixner W et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 1998; 76(1-2):71-81.
37. Price DD, Bennett GJ, Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain 1989; 36(3):273-288.
38. Arendt-Nielsen L. Induction and assessment of experimental pain from human skin, muscle, and viscera. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z, eds. Proceedings of the 8th World Congress on Pain. Seattle: IASP Press, 1997:393.
39. Collins WF, Nulsen FE, Randt CT. Relation of peripheral nerve fiber size and sensation in man. Arch Neurol (Chic) 1960; 3:381-385.
40. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001; 93(1):7-14.
41. Mertz H et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109(1):40-52.
42. Naliboff BD et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41(4):505-512.
43. Accarino AM, Azpiroz F, Malagelada JR. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995; 108(3):636-643.
44. Cook IJ, van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987; 93(4):727-733.
45. Whitehead WE et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenter-ology 1990; 98(5 Pt 1):1187-1192.
46. Zighelboim J et al. Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995; 40(4):819-827.
47. Bouin M et al. Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition?. Dig Dis Sci 2001; 46(11):2542-2548.
48. Chang L et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000; 84(2-3):297-307.
49. Dunphy RC et al. Visceral and cutaneous hypersensitivity in Persian Gulf War veterans with chronic gastrointestinal symptoms. Pain 2003; 102(1-2):79-85.
50. Gupta V, Sheffield D, Verne GN. Evidence for autonomic dysregulation in the irritable bowel syndrome. Dig Dis Sci 2002; 47(8):1716-1722.
51. Verne GN et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003; 103(1-2):99-110.
52. Verne GN et al. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003; 105(1-2):223-230.
53. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990; 99(6):1688-1704.
54. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107(1):271-293.
55. Al Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000; 119(5): 1276-1285.
56. Zhou Q et al. Visceral somatic convergence in TNBS induced colitis in rats, J Pain 2005; 7(4):330.
57. Mertz H et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000; 118(5):842-848.
58. Naliboff BD et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001; 63(3):365-375.
59. Silverman DH, Phelps ME. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?. J Nucl Med 2000; 41(11):1929-1932.
60. Yuan YZ et al. Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World J Gastroenterol 2003; 9(6):1356-1360.
61. Price DD et al. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clin J Pain 1998; 14(3):216-226.
62. Vase L et al. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003; 105(1-2):17-25.
63. Vase L, Riley JL III, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 2002; 99(3):443-452.
64. Verne GN, Price DD. Irritable bowel syndrome as a common precipitant of central sensitization. Curr Rheumatol Rep 2002; 4(4):322-328.
65. Verne GN, Sen A, Price DD. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome. J Pain 2005; 6(8):493-496.
66. Robinson ME, Riley JL. Negative emotion in pain. In: Gatchel R, Turk D, eds. Psychosocial Factors in Pain. New York: Guilford Press, 1998.
67. Ploghaus A et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 2001; 21(24):9896-9903.
68. Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain 2000; 84(1):65-75.
69. Rhudy JL, Meagher MW. Negative affect: effects on an evaluative measure of human pain. Pain 2003; 104(3):617-626.
70. Zelman DC et al. The effects of induced mood on laboratory pain. Pain 1991; 46(1):105-111.
71. McCracken LM, Gross RT. The role of pain-related anxiety reduction in the outcome of multidisci-plinary treatment for chronic low back pain: preliminary results. J Occup Rehabil 1998; 8:179-189.
72. Vase L et al. The contributions of changes in expected pain levels and desire for pain relief to placebo analgesia. In: Price DD, Bushnell MC, eds. Psychological Methods of Pain Control: Basic Science and Clinical Perspectives. Seattle, WA: IASP Press, 2004:207-232.
Was this article helpful?